7Baggers
 Bio-Path Holdings announces board resignation and outlines turnaround plans  Investing.com Nigeria Fri, 14 Nov 2025 17:41:50 GMT
 Bio-Path Holdings Seeks Financing for Strategic Turnaround  TipRanks Fri, 14 Nov 2025 17:31:34 GMT
 Bio-Path (BPTH) Projected to Post Earnings on Thursday  Defense World Thu, 06 Nov 2025 06:37:14 GMT
 bridgebio aces phase 3 rare disease test, clearing path to fda  Fierce Biotech Mon, 27 Oct 2025 07:00:00 GMT
 bio-path holdings provides clinical and operational update  ADVFN Mon, 06 Oct 2025 01:12:23 GMT
 bio-path readies for key 2025 clinical milestones by investing.com  Investing.com Nigeria Wed, 01 Oct 2025 07:00:00 GMT
 fda waives trial requirement for stelera biosimilar, easing the copycat’s path  European Pharmaceutical Review Tue, 02 Sep 2025 07:00:00 GMT
 morgan wallen’s latest milestone proves he’s one of this century’s biggest artists  Biography: Historical and Celebrity Profiles Mon, 25 Aug 2025 07:00:00 GMT
 bio-path: q2 earnings snapshot  Norwalk Hour Fri, 15 Aug 2025 04:08:47 GMT
 bio-path: q2 earnings snapshot  San Francisco Chronicle Thu, 14 Aug 2025 07:00:00 GMT
 bio-path holdings, inc. sec 10-q report  TradingView Thu, 14 Aug 2025 07:00:00 GMT
 bio-path (bpth) projected to post earnings on thursday  Defense World Thu, 14 Aug 2025 05:51:24 GMT
 bio-path holdings dismisses ernst & young as auditor, seeks new firm  Investing.com UK Wed, 13 Aug 2025 21:40:00 GMT
 sirnas could provide alternative treatment path for vision loss  BioXconomy Tue, 12 Aug 2025 07:00:00 GMT
 subtyping beats a path towards precision medicine in alzheimer’s  BioWorld MedTech Tue, 05 Aug 2025 14:59:58 GMT
 bio-path holdings, inc. (nasdaq:bpth) short interest update  Defense World Sat, 02 Aug 2025 05:46:23 GMT
 kanchi leads way with bio-mining, sewage, canal work  Times of India Tue, 29 Jul 2025 21:02:00 GMT
 radiopharma-focused artbio paints path to clinic with $132m series b  Fierce Biotech Tue, 29 Jul 2025 07:00:00 GMT
 intelligent bio solutions accelerates global growth with  GlobeNewswire Wed, 16 Jul 2025 07:00:00 GMT

Bio-Path Holdings, Inc
(NASDAQ:BPTH) 

BPTH stock logo

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA...

Founded: 2000
Full Time Employees: 9
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends